A Case of Growth Failure Caused by 13-CIS-Retinoic Acid Administration after Bone Marrow Transplantation for Neuroblasoma.

Accession number;99A0391907
Title;A Case of Growth Failure Caused by 13-CIS-Retinoic Acid Administration after Bone Marrow Transplantation for Neuroblasoma.
Author; INAMOTO Y (Nihon Univ., Tokyo, Jpn) SUZUKI T (Nihon Univ. School Of Medicine, Tokyo, Jpn) MUGISHIMA H (Nihon Univ. School Of Medicine, Tokyo, Jpn)
Journal Title;Endocr J
Journal Code:F0625A
ISSN:0918-8959
VOL.46;NO.Supplement;PAGE.S113-S115(1999)
Figure&Table&Reference;FIG.2, REF.2
Pub. Country;Japan
Language;English
Abstract;We report an 11-year-old girl with growth failure caused by long-term administration of 13-cis-retinoic acid after bone marrow transplantation for neuroblastoma. Her growth velocity was 1-2 cm/year after 13-cis-retinoic acid administration. Her endocrinological findings were normal except for peak growth hormone levels of 6.4 ng/ml (clonidine) and 9.7 ng/ml (arginine). IGF-1 and IGFBP-3 were normal. It is not possible to conclude that her severe growth failure was caused by partial growth hormone deficiency, but premature epiphyseal closure was seen on radiographic examination. We concluded that the growth failure was caused by pediatric cancer therapy for the musculoskeletal system but not by endocrinological disturbance. (author abst.)
FULLTEXT